Blog
RSS FeedPosted by Michael Wonder on 10 Apr 2019
PHARMAC's consideration of Ibrance and Kadcyla - what we know and what we don't
11 April 2019 - The information in the public domain reveals PHARMAC's opacity and tardiness in its consideration of pabociclib ...
Posted by Michael Wonder on 10 Apr 2019
Breast cancer drug advocate lashes out at Labour after PHARMAC inquiry blocked
10 April 2019 - An advocate for a breast cancer drug has lashed out at Labour politicians for blocking an ...
Posted by Michael Wonder on 09 Apr 2019
More funding sought for lung cancer treatments
9 April 2019 - Lung cancer patients are not getting a fair go, says the New Zealand Lung Foundation. ...
Posted by Michael Wonder on 09 Apr 2019
Official inquiry into PHARMAC necessary
10 April 2019 - Today National MP Michael Woodhouse is set to table a motion calling on the Health Select ...
Posted by Michael Wonder on 08 Apr 2019
Greater flexibility needed by PHARMAC to fund new medicines, including cancer drug - expert
8 April 2019 - The fight continues in New Zealand for funding of a life-prolonging drug that targets advanced breast ...
Posted by Michael Wonder on 07 Apr 2019
Grandmothers lobby government for rare genetic disease medication
7 April 2019 - Two grandmothers will help deliver a petition to parliament next month calling for funding for a ...
Posted by Michael Wonder on 03 Apr 2019
Drug companies call out PHARMAC for lack of transparency and timeliness
3 April 2019 - Two of the world's largest pharmaceutical companies say New Zealand is lagging behind other countries when ...
Posted by Michael Wonder on 01 Apr 2019
PHARMAC called out over failure to fund breast cancer drug Ibrance
2 April 2019 - PHARMAC is being called out for trailing behind Australia when it comes to funding breast cancer ...
Posted by Michael Wonder on 01 Apr 2019
New Zealand Pharmaceutical Schedule - 1 April 2019 update
1 April 2019 - The April 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Mar 2019
Major incorrect fact in the Annual Review of PHARMAC
28 March 2019 - Today the Health Select Committee released their 2017/2018 Annual Review of PHARMAC. Sadly, and disappointingly, it ...
Posted by Michael Wonder on 28 Mar 2019
'Declare lung cancer national priority' - Lung Foundation NZ
28 March 2019 - The latest call for better cancer treatment funding has come from Lung Foundation New Zealand which ...
Posted by Michael Wonder on 27 Mar 2019
Whanganui District Health Board says small number of patients affects cancer treatment wait time results
28 March 2019 - Whanganui District Health Board failed to meet the national faster cancer treatment target in January. ...
Posted by Michael Wonder on 27 Mar 2019
Cancer advocate: PHARMAC is 'compromised' by limited spending
27 March 2019 - Malcolm Mulholland says he has been told that oncologists advising PHARMAC feel uncomfortable with their practices. ...
Posted by Michael Wonder on 26 Mar 2019
PHARMAC defends not funding expensive breast cancer drugs
26 March 2019 - PHARMAC is defending their decision not to fund certain breast cancer drugs. ...
Posted by Michael Wonder on 26 Mar 2019
Cancer Society critical of PHARMAC saying they 'lack accountability, lack transparency, are slow'
26 March 2019 - PHARMAC "lack accountability, lack transparency, are slow", in delivering pharmaceutical drugs to New Zealanders who need ...